Androgen priming in the late luteal phase as a mean to improve the outcome of ovarian stimulation for IVF in normogonadotrophic women with a previously proven poor response - Androgen priming

Fertility clinic Odense University Hospital0 个研究点目标入组 20 人开始时间: 2005年9月1日最近更新: 2012年3月19日

适应症

试验速览

暂无简介。

•Inclusion criteria; Normogonadotropic, healthy women < 40 years old, who in a previous IVF or ICSI attempt has shown the characteristics of a low responder as defined above.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Exclusion criteria;
•Any clinically significant systemic disease (e.g., insulin dependent diabetes) or endocrine/metabolic disease, any concomitant medications that would interfere with evaluation of study medications (non-study hormonal therapy - except for thyroid medication, NSAIDs - including aspirin, and psychotropic agents (phenothiazine’s, major tranquillisers) at the time of study entry and during the study.
•Abuse of alcohol or drugs, history of chemotherapy or radiotherapy, any clinically relevant abnormal laboratory value, use of any non registered investigational drugs during 3 months before screening or previous participation in the study, pregnancy, lactation or contraindication to pregnancy – must be confirmed by negative pregnancy test on CD 24. i.e. at the time of entry into the study.

发起方

Fertility clinic Odense University Hospital